Michael Lugez
About Michael Lugez
Michael Lugez is the Vice President & General Manager for Switzerland and Austria at Bristol Myers Squibb, with extensive experience in the pharmaceutical industry across multiple countries.
Current Role at Bristol Myers Squibb
As of September 2021, Michael Lugez holds the position of Vice President & General Manager for Switzerland and Austria at Bristol Myers Squibb. He is based in Suisse and is responsible for overseeing operations in these two countries. His role involves strategic leadership and management to ensure the company's success in these critical markets.
Previous Roles at Bristol Myers Squibb
Prior to his current role, Michael Lugez served as the General Manager for Sweden at Bristol Myers Squibb from 2019 to 2021. During his tenure in Stockholm, he contributed significantly to the company's operations and growth in the Swedish market.
Leadership Experience at Celgene
Michael Lugez brought his expertise to Celgene, where he worked as the General Manager for the Nordics from 2018 to 2021. He also served as the Business Unit Director for Inflammation & Immunology from 2014 to 2018. His work at Celgene in the Paris Area, France, and Stockholm significantly impacted the company's regional operations and patient care initiatives.
Career with Pfizer
At Pfizer, Michael Lugez held a series of significant leadership positions. Key roles included Commercial Lead for Inflammation, Commercial Lead for Specialty Care, Sales Director for Primary Care BU, and Strategic Marketing Director for Rheumatology/Dermatology. His extensive tenure at Pfizer also saw him directing Information Solutions & Systems in both France and the UK, showcasing his versatility and expertise in various domains.
Educational Background
Michael Lugez completed his MBA with a focus on Information Systems at IAE FRANCE - La Sorbonne from 2001 to 2003. He also holds an Associate Degree in Information Systems from College, obtained between 1991 and 1993. His formal education has underpinned his successful career in the pharmaceutical industry, particularly in information solutions and business operations.